Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis
- PMID: 16816897
- DOI: 10.1007/s00406-006-0612-3
Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis
Abstract
Neurocysticercosis is the most frequent parasitic infection of the CNS and the main cause of acquired epilepsy worldwide. Seizures are the most common symptoms of the disease, together with headache, involuntary movements, psychosis and a global mental deterioration. Absolute diagnostic criteria include the identification of cysticerci, with scolex, in the brain by MRI imaging. We demonstrate here, for the first time, that T. solium DNA is present in the cerebrospinal fluid of patients. The PCR amplification of the parasite DNA in the CSF enabled the correct identification of 29/30 cases (96.7 %). The PCR diagnosis of parasite DNA in the CSF may be a strong support for the diagnosis of neurocysticercosis.
Similar articles
-
Neurocysticercosis: detection of Taenia solium DNA in human cerebrospinal fluid using a semi-nested PCR based on HDP2.Ann Trop Med Parasitol. 2008 Jun;102(4):317-23. doi: 10.1179/136485908X278856. Ann Trop Med Parasitol. 2008. PMID: 18510812
-
Evaluation of Taenia solium and Taenia crassiceps cysticercal antigens for immunodiagnosis of neurocysticercosis using ELISA on cerebrospinal fluid samples.Rev Soc Bras Med Trop. 2007 Mar-Apr;40(2):152-5. doi: 10.1590/s0037-86822007000200002. Rev Soc Bras Med Trop. 2007. PMID: 17568880
-
Evaluation of Taenia solium and Taenia crassiceps cysticercal antigens for the serodiagnosis of neurocysticercosis.Trop Med Int Health. 2005 Oct;10(10):1005-12. doi: 10.1111/j.1365-3156.2005.01480.x. Trop Med Int Health. 2005. PMID: 16185235
-
Diagnostic criteria for neurocysticercosis, revisited.Pathog Glob Health. 2012 Sep;106(5):299-304. doi: 10.1179/2047773212Y.0000000025. Pathog Glob Health. 2012. PMID: 23265554 Free PMC article. Review.
-
Neurocysticercosis.Handb Clin Neurol. 2014;121:1445-59. doi: 10.1016/B978-0-7020-4088-7.00097-3. Handb Clin Neurol. 2014. PMID: 24365429 Review.
Cited by
-
Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management.Pathog Glob Health. 2012 Sep;106(5):261-74. doi: 10.1179/2047773212Y.0000000047. Pathog Glob Health. 2012. PMID: 23265550 Free PMC article. Review.
-
Neurocysticercosis: Five new things.Neurol Clin Pract. 2013 Apr;3(2):118-125. doi: 10.1212/CPJ.0b013e31828d9f17. Neurol Clin Pract. 2013. PMID: 23914321 Free PMC article.
-
High prevalence of cysticercosis in people with epilepsy in southern Rwanda.PLoS Negl Trop Dis. 2013 Nov 14;7(11):e2558. doi: 10.1371/journal.pntd.0002558. eCollection 2013 Nov. PLoS Negl Trop Dis. 2013. PMID: 24244783 Free PMC article.
-
Confirmation and follow-up of neurocysticercosis by real-time PCR in cerebrospinal fluid samples of patients living in France.J Clin Microbiol. 2011 Dec;49(12):4338-40. doi: 10.1128/JCM.05839-11. Epub 2011 Oct 5. J Clin Microbiol. 2011. PMID: 21976768 Free PMC article.
-
Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections.Clin Microbiol Rev. 2024 Dec 10;37(4):e0002124. doi: 10.1128/cmr.00021-24. Epub 2024 Oct 15. Clin Microbiol Rev. 2024. PMID: 39404267 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources